| Dr Stacia E Schmidt, DPT | |
|
1650 S 41st St, Manitowoc, WI 54220-7316 | |
| (920) 320-2250 | |
| Not Available |
| Full Name | Dr Stacia E Schmidt |
|---|---|
| Gender | Female |
| Speciality | Physical Therapy |
| Experience | 18 Years |
| Location | 1650 S 41st St, Manitowoc, Wisconsin |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1376653956 | NPI | - | NPPES |
| 40393800 | Medicaid | WI |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2251X0800X | Physical Therapist - Orthopedic | 10034-024 (Wisconsin) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| St. Nicholas Hospital-sisters Of The Third Order Of St Francis | 8325931652 | 150 |
News Archive
RXi Pharmaceuticals Corporation, a recognized leader in RNAi-based therapeutics, announced today that, as part of its collaboration with miRagen Therapeutics, positive data were generated demonstrating that RXi's sd-rxRNA technology can be used, in vitro, to specifically enhance the activity of a microRNA of high interest to miRagen.
Array BioPharma Inc. today announced results from a randomized Phase 2 placebo-controlled study conducted by AstraZeneca comparing the efficacy of selumetinib in combination with docetaxel with docetaxel alone in the second-line treatment of 87 patients prospectively selected with KRAS-mutant, locally advanced or metastatic non-small cell lung cancer.
According to a new study, women who have severe skin wrinkles during the first few years of menopause also appear to have lower bone mineral density.
An Australian researcher has identified genes which could make some children more susceptible to the deadly Kawasaki disease - an inflammatory condition in young children that can damage blood vessels.
A team of computer scientists from the University of Delaware and Georgetown University has developed a new system to rapidly determine which cancer drugs are likely to work best given a patient's genetic markers.
› Verified 2 days ago
| Provider Name | St. Nicholas Hospital-sisters Of The Third Order Of St Francis |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1275799413 PECOS PAC ID: 8325931652 Enrollment ID: O20040202001172 |
News Archive
RXi Pharmaceuticals Corporation, a recognized leader in RNAi-based therapeutics, announced today that, as part of its collaboration with miRagen Therapeutics, positive data were generated demonstrating that RXi's sd-rxRNA technology can be used, in vitro, to specifically enhance the activity of a microRNA of high interest to miRagen.
Array BioPharma Inc. today announced results from a randomized Phase 2 placebo-controlled study conducted by AstraZeneca comparing the efficacy of selumetinib in combination with docetaxel with docetaxel alone in the second-line treatment of 87 patients prospectively selected with KRAS-mutant, locally advanced or metastatic non-small cell lung cancer.
According to a new study, women who have severe skin wrinkles during the first few years of menopause also appear to have lower bone mineral density.
An Australian researcher has identified genes which could make some children more susceptible to the deadly Kawasaki disease - an inflammatory condition in young children that can damage blood vessels.
A team of computer scientists from the University of Delaware and Georgetown University has developed a new system to rapidly determine which cancer drugs are likely to work best given a patient's genetic markers.
› Verified 2 days ago
| Provider Name | St Vincent Hospital-hospital Sisters-third Order Of St Francis |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1285613638 PECOS PAC ID: 5799694675 Enrollment ID: O20080620000423 |
News Archive
RXi Pharmaceuticals Corporation, a recognized leader in RNAi-based therapeutics, announced today that, as part of its collaboration with miRagen Therapeutics, positive data were generated demonstrating that RXi's sd-rxRNA technology can be used, in vitro, to specifically enhance the activity of a microRNA of high interest to miRagen.
Array BioPharma Inc. today announced results from a randomized Phase 2 placebo-controlled study conducted by AstraZeneca comparing the efficacy of selumetinib in combination with docetaxel with docetaxel alone in the second-line treatment of 87 patients prospectively selected with KRAS-mutant, locally advanced or metastatic non-small cell lung cancer.
According to a new study, women who have severe skin wrinkles during the first few years of menopause also appear to have lower bone mineral density.
An Australian researcher has identified genes which could make some children more susceptible to the deadly Kawasaki disease - an inflammatory condition in young children that can damage blood vessels.
A team of computer scientists from the University of Delaware and Georgetown University has developed a new system to rapidly determine which cancer drugs are likely to work best given a patient's genetic markers.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Stacia E Schmidt, DPT 2300 Western Ave, Po Box 2170, Manitowoc, WI 54220-3712 Ph: (920) 320-8667 | Dr Stacia E Schmidt, DPT 1650 S 41st St, Manitowoc, WI 54220-7316 Ph: (920) 320-2250 |
News Archive
RXi Pharmaceuticals Corporation, a recognized leader in RNAi-based therapeutics, announced today that, as part of its collaboration with miRagen Therapeutics, positive data were generated demonstrating that RXi's sd-rxRNA technology can be used, in vitro, to specifically enhance the activity of a microRNA of high interest to miRagen.
Array BioPharma Inc. today announced results from a randomized Phase 2 placebo-controlled study conducted by AstraZeneca comparing the efficacy of selumetinib in combination with docetaxel with docetaxel alone in the second-line treatment of 87 patients prospectively selected with KRAS-mutant, locally advanced or metastatic non-small cell lung cancer.
According to a new study, women who have severe skin wrinkles during the first few years of menopause also appear to have lower bone mineral density.
An Australian researcher has identified genes which could make some children more susceptible to the deadly Kawasaki disease - an inflammatory condition in young children that can damage blood vessels.
A team of computer scientists from the University of Delaware and Georgetown University has developed a new system to rapidly determine which cancer drugs are likely to work best given a patient's genetic markers.
› Verified 2 days ago
Jessica L Chouinard, PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 2300 Western Ave, Manitowoc, WI 54220 Phone: 920-320-8667 Fax: 920-320-8616 | |
Rachel R Fischer, PT Physical Therapist Medicare: Medicare Enrolled Practice Location: 3415 Custer St Ste D, Manitowoc, WI 54220 Phone: 920-652-9310 Fax: 920-652-9316 | |
Ms. Katherine Ann Pohlmann, P.T. Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 2262 Knuell St, Manitowoc, WI 54220 Phone: 920-652-0930 | |
Nicole Drew, PT Physical Therapist Medicare: Medicare Enrolled Practice Location: 1650 S 41st St, Manitowoc, WI 54220 Phone: 920-320-3100 Fax: 920-320-5114 | |
Mr. Adam B Klarkowski, PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 1212 Memorial Dr, Ste 1, Manitowoc, WI 54220 Phone: 920-652-9554 Fax: 920-652-9556 | |
Damon J Banks, PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 960 S Rapids Rd, Manitowoc, WI 54220 Phone: 920-684-1144 | |
Kelsey Hoffman, PHYSICAL THERAPIST Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 1650 S 41st St, Manitowoc, WI 54220 Phone: 920-320-3100 Fax: 920-684-3194 |